References
- Tavakkol A, Pollak R, Harkless L, et al. Toenail assessment tool for quantification of visibly infected mycotic nail plate in onychomycosis. Cutis. 2007;80:488–494.
- Werschler WP, Bondar G, Armstrong D. Assessing treatment outcomes in toenail onychomycosis clinical trials. Am J Clin Dermatol. 2004;5:145–152.
- Ginarte M, Garcia-Doval I, Manteagudo B, et al. Observer agreement in toenail disorders: implications for diagnosis and clinical research. Br J Dermatol. 2009;160:1315–1317.
- Fletcher CL, Hay RJ, Smeeton NC. Observer agreement in recording the clinical signs of nail disease and the accuracy of a clinical diagnosis of fungal and non-fungal nail disease. Br J Dermatol. 2003;148:558–562.
- Kwon YH, Adix M, Zimmerman MB, et al. Variance owing to observer, repeat imaging, and fundus camera type on cup-to-disk ratio estimates by stereo planimetry. J Glaucoma. 2009;18:305–310.
- Gupta AK. A randomized evaluator-blind study of ciclopirox-terbinafine combination therapy versus terbinafine monotherapy for the treatment of dermatophyte toenail onychomycosis. P1806. J Am Acad Dermatol. 2007;56:AB125.
- Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327:307–310.
- Hick J, Feldman SR. Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments. J Am Acad Dermatol. 2007;57:972–976.